Literature DB >> 10030734

Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer.

T Suzuki1, T Ochiai, H Hayashi, K Nakajima, A Yasumoto, E Hishikawa, H Shimada, F Horiuchi, S Ohki, K Isono.   

Abstract

Although peritoneal lavage cytology is widely performed during surgery for gastric cancer and the results have been reported to be one of the accurate prognostic factors, the cancer stage is determined independent of the results of lavage cytology according to the First English Edition of Japanese Classification of Gastric Carcinoma. In this study we demonstrated the validity of lavage cytology for accurately staging gastric cancer. Between 1988 and 1996, peritoneal lavage cytology was performed in 347 patients with resectable gastric cancer. Among them, cytology was positive in 29 cases (8.4%). The survival rate of the cytology-positive patients in each stage was worse than that of all patients in the same stage. The prognosis of patients with positive cytology findings and serosa-exposed gastric cancer was significantly worse than that of negative cytology findings and serosa-exposed gastric cancer, and similar to that of negative cytology findings and serosa-infiltrating gastric cancer. Our data indicated that positive cytology findings thus indicated a poor prognosis, and the prognostic difference between positive and negative cytology findings was approximately a one-stage difference in the Japanese stage grouping. Based on our findings, the results of peritoneal lavage cytology should thus be included in the factors for staging gastric cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10030734     DOI: 10.1007/BF02482234

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Assessment of the exfoliation of tumor cells into the body cavities.

Authors:  G E MOORE; K SAKO; T KONDO; J BADILLO; E BURKE
Journal:  Surg Gynecol Obstet       Date:  1961-04

Review 2.  [Adjuvant chemotherapy for advanced gastric cancer].

Authors:  H Furukawa; M Hiratsuka; T Iwanaga; S Imaoka; O Ishikawa; T Kabuto; Y Sasaki; M Kameyama; H Ohigashi; S Nakamori; H Nakano; T Yasuda
Journal:  Nihon Geka Gakkai Zasshi       Date:  1996-04

3.  Prognostic and therapeutic values of peritoneal cytology in gastric cancer.

Authors:  T Nakajima; S Harashima; M Hirata; T Kajitani
Journal:  Acta Cytol       Date:  1978 Jul-Aug       Impact factor: 2.319

4.  Proposal of a risk score for recurrence in patients with curatively resected gastric cancer.

Authors:  T Ichikura; K Fujino; H Ikawa; S Tomimatsu; K Uefuji; S Tamakuma
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

5.  Intraperitoneal free cancer cells and their viability in gastric cancer.

Authors:  Y Iitsuka; S Kaneshima; O Tanida; T Takeuchi; S Koga
Journal:  Cancer       Date:  1979-10       Impact factor: 6.860

6.  A pilot study of intraperitoneal cisplatin in the management of gastric cancer.

Authors:  A L Jones; P Trott; D Cunningham; R D Rosin; D Coleman; P Sauven; G Glazer; D Cunningham; J Hermon-Taylor; R C Coombes
Journal:  Ann Oncol       Date:  1994-02       Impact factor: 32.976

7.  Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer.

Authors:  T Boku; Y Nakane; T Minoura; H Takada; M Yamamura; K Hioki; M Yamamoto
Journal:  Br J Surg       Date:  1990-04       Impact factor: 6.939

8.  Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group.

Authors:  J R Siewert; K Böttcher; J D Roder; R Busch; P Hermanek; H J Meyer
Journal:  Br J Surg       Date:  1993-08       Impact factor: 6.939

9.  Peritoneal dissemination after a curative gastrectomy in patients with undifferentiated adenocarcinoma of the stomach.

Authors:  S Ohno; Y Maehara; H Ohiwa; T Oshiro; Y Kakeji; H Baba; M Furusawa; K Sugimachi
Journal:  Semin Surg Oncol       Date:  1994 Mar-Apr

10.  Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer.

Authors:  M Ikeguchi; A Oka; S Tsujitani; M Maeta; N Kaibara
Journal:  Anticancer Res       Date:  1994 Sep-Oct       Impact factor: 2.480

View more
  11 in total

1.  Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients.

Authors:  Y T Lee; E K W Ng; L C T Hung; S C S Chung; J Y L Ching; W Y Chan; W C Chu; J J Sung
Journal:  Gut       Date:  2005-06-13       Impact factor: 23.059

2.  Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection?

Authors:  Ulysses Ribeiro; Adriana V Safatle-Ribeiro; Bruno Zilberstein; Donato Mucerino; Osmar Kenji Yagi; Cláudio Caldas Bresciani; Carlos Eduardo Jacob; Kyioshi Iryia; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

3.  Prognostic significance of peritoneal washing cytology in Thai patients with gastric adenocarcinoma undergoing curative D2 gastrectomy.

Authors:  Chakrapan Euanorasetr; Panuwat Lertsithichai
Journal:  Gastric Cancer       Date:  2007-02-23       Impact factor: 7.370

Review 4.  Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patients.

Authors:  Shunsuke Kagawa; Kunitoshi Shigeyasu; Michihiro Ishida; Megumi Watanabe; Hiroshi Tazawa; Takeshi Nagasaka; Yasuhiro Shirakawa; Toshiyoshi Fujiwara
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  [Acute traumatic abdominal wall hernia after blunt abdominal trauma].

Authors:  D Brett; D Seybold; S Michalski; G Muhr
Journal:  Unfallchirurg       Date:  2008-05       Impact factor: 1.000

6.  Laparoscopy alone is superior to peritoneal cytology in staging gastric and esophageal carcinoma.

Authors:  M B Wilkiemeyer; S C Bieligk; R Ashfaq; D B Jones; R V Rege; J B Fleming
Journal:  Surg Endosc       Date:  2004-04-02       Impact factor: 4.584

7.  Clinical significance of telomerase activity in peritoneal lavage fluid from patients with gastric cancer and its relationship with cellular proliferation.

Authors:  Ming-Xu Da; Xiao-Ting Wu; Tian-Kang Guo; Zi-Guang Zhao; Ting Luo; Kun Qian; Ming-Ming Zhang; Jie Wang
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

8.  Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer.

Authors:  G de Manzoni; G Verlato; A Di Leo; A Tomezzoli; C Pedrazzani; F Pasini; Q Piubello; C Cordiano
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.282

9.  Prognostic value of genetic detection using CEA and MAGE in peritoneal washes with gastric carcinoma after curative resection: result of a 3-year follow-up.

Authors:  Chang-Ho Jeon; In-Ho Kim; Hyun-Dong Chae
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

10.  Integrated fluorescent cytology with nano-biologics in peritoneally disseminated gastric cancer.

Authors:  Megumi Watanabe; Shunsuke Kagawa; Kazuya Kuwada; Yuuri Hashimoto; Kunitoshi Shigeyasu; Michihiro Ishida; Shuichi Sakamoto; Atene Ito; Satoru Kikuchi; Shinji Kuroda; Hiroyuki Kishimoto; Shuta Tomida; Ryuichi Yoshida; Hiroshi Tazawa; Yasuo Urata; Toshiyoshi Fujiwara
Journal:  Cancer Sci       Date:  2018-09-23       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.